Joshua R Dyer1, Ryan Williams, Charles H Bombardier, Steven Vannoy, Jesse R Fann. 1. Department of Rehabilitation Medicine (Drs Dyer and Bombardier), and Department of Psychiatry and Behavioral Sciences (Dr Fann), University of Washington School of Medicine, Seattle, Washington; American Institutes for Research, Chicago, Illinois (Dr Williams); and Department of Counseling and School Psychology, University of Massachusetts, Boston, Massachusetts (Dr Vannoy).
Abstract
OBJECTIVES: To explore the psychometric properties of 3 widely used measures of depression in a sample of individuals with traumatic brain injury (TBI) and major depressive disorder and refine them to maximize efficiency. DESIGN: Secondary analysis of data from a randomized controlled trial of cognitive-behavioral therapy for depression after TBI. SETTING: Nationwide recruitment from community and clinical settings. PARTICIPANTS: One hundred adults within 10 years of complicated mild to severe TBI. INTERVENTION: Telephone and in-person cognitive-behavioral therapy. MAIN MEASURES: Patient Health Questionnaire-9 (PHQ-9), Symptom Checklist-20, and Hamilton Depression Rating Scale. RESULTS: We used Rasch rating scale analysis and multilevel modeling to investigate the 3 measures. Measurement properties of each of the depression measures were strong. We explored modifications to the rating scales to improve efficiency while retaining strong psychometric characteristics. Correlations among these revised measures were high. Treatment effects of each revised depression measure were compared using a multilevel model, and effect size estimates were comparable among the revised PHQ-9, Symptom Checklist-20, and Hamilton Depression Rating Scale. CONCLUSIONS: Although each of the 3 measures demonstrated adequate reliability, the efficiency of all 3 instruments was improved with rating scale analysis. The PHQ-9 required the fewest modifications and functions well as a measure of depression among those with TBI.
RCT Entities:
OBJECTIVES: To explore the psychometric properties of 3 widely used measures of depression in a sample of individuals with traumatic brain injury (TBI) and major depressive disorder and refine them to maximize efficiency. DESIGN: Secondary analysis of data from a randomized controlled trial of cognitive-behavioral therapy for depression after TBI. SETTING: Nationwide recruitment from community and clinical settings. PARTICIPANTS: One hundred adults within 10 years of complicated mild to severe TBI. INTERVENTION: Telephone and in-person cognitive-behavioral therapy. MAIN MEASURES: Patient Health Questionnaire-9 (PHQ-9), Symptom Checklist-20, and Hamilton Depression Rating Scale. RESULTS: We used Rasch rating scale analysis and multilevel modeling to investigate the 3 measures. Measurement properties of each of the depression measures were strong. We explored modifications to the rating scales to improve efficiency while retaining strong psychometric characteristics. Correlations among these revised measures were high. Treatment effects of each revised depression measure were compared using a multilevel model, and effect size estimates were comparable among the revised PHQ-9, Symptom Checklist-20, and Hamilton Depression Rating Scale. CONCLUSIONS: Although each of the 3 measures demonstrated adequate reliability, the efficiency of all 3 instruments was improved with rating scale analysis. The PHQ-9 required the fewest modifications and functions well as a measure of depression among those with TBI.
Authors: Charles H Bombardier; Jesse R Fann; Evette J Ludman; Steven D Vannoy; Joshua R Dyer; Jason K Barber; Nancy R Temkin Journal: J Head Trauma Rehabil Date: 2017 Sep/Oct Impact factor: 2.710
Authors: Murray B Stein; Sonia Jain; Joseph T Giacino; Harvey Levin; Sureyya Dikmen; Lindsay D Nelson; Mary J Vassar; David O Okonkwo; Ramon Diaz-Arrastia; Claudia S Robertson; Pratik Mukherjee; Michael McCrea; Christine L Mac Donald; John K Yue; Esther Yuh; Xiaoying Sun; Laura Campbell-Sills; Nancy Temkin; Geoffrey T Manley; Opeolu Adeoye; Neeraj Badjatia; Kim Boase; Yelena Bodien; M Ross Bullock; Randall Chesnut; John D Corrigan; Karen Crawford; Ramon Diaz-Arrastia; Sureyya Dikmen; Ann-Christine Duhaime; Richard Ellenbogen; V Ramana Feeser; Adam Ferguson; Brandon Foreman; Raquel Gardner; Etienne Gaudette; Joseph T Giacino; Luis Gonzalez; Shankar Gopinath; Rao Gullapalli; J Claude Hemphill; Gillian Hotz; Sonia Jain; Frederick Korley; Joel Kramer; Natalie Kreitzer; Harvey Levin; Chris Lindsell; Joan Machamer; Christopher Madden; Alastair Martin; Thomas McAllister; Michael McCrea; Randall Merchant; Pratik Mukherjee; Lindsay D Nelson; Florence Noel; David O Okonkwo; Eva Palacios; Daniel Perl; Ava Puccio; Miri Rabinowitz; Claudia S Robertson; Jonathan Rosand; Angelle Sander; Gabriela Satris; David Schnyer; Seth Seabury; Mark Sherer; Murray B Stein; Sabrina Taylor; Arthur Toga; Nancy Temkin; Alex Valadka; Mary J Vassar; Paul Vespa; Kevin Wang; John K Yue; Esther Yuh; Ross Zafonte Journal: JAMA Psychiatry Date: 2019-03-01 Impact factor: 21.596
Authors: Jesse R Fann; Charles H Bombardier; Nancy Temkin; Peter Esselman; Catherine Warms; Jason Barber; Sureyya Dikmen Journal: J Head Trauma Rehabil Date: 2017 Sep/Oct Impact factor: 2.710
Authors: Rebecca M Saracino; Ezgi Aytürk; Heining Cham; Barry Rosenfeld; Leah M Feuerstahler; Christian J Nelson Journal: Psychol Assess Date: 2019-08-08
Authors: Noah D Silverberg; Thalia Otamendi; Penelope Ma Brasher; Jeffrey R Brubacher; Linda C Li; Pierre-Paul Lizotte; William J Panenka; Frank X Scheuermeyer; Patrick Archambault Journal: BMJ Open Date: 2022-06-21 Impact factor: 3.006